Synthesis of a Coumarin-Based PPARγ Fluorescence Probe for Competitive Binding Assay

Peroxisome proliferator-activated receptor γ (PPARγ) is a molecular target of metabolic syndrome and inflammatory disease. PPARγ is an important nuclear receptor and numerous PPARγ ligands were developed to date; thus, efficient assay methods are important. Here, we investigated the incorporation of...

Full description

Bibliographic Details
Main Authors: Chisato Yoshikawa, Hiroaki Ishida, Nami Ohashi, Toshimasa Itoh
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/8/4034
Description
Summary:Peroxisome proliferator-activated receptor γ (PPARγ) is a molecular target of metabolic syndrome and inflammatory disease. PPARγ is an important nuclear receptor and numerous PPARγ ligands were developed to date; thus, efficient assay methods are important. Here, we investigated the incorporation of 7-diethylamino coumarin into the PPARγ agonist rosiglitazone and used the compound in a binding assay for PPARγ. PPARγ-ligand-incorporated 7-methoxycoumarin, <b>1</b>, showed weak fluorescence intensity in a previous report. We synthesized PPARγ-ligand-incorporating coumarin, <b>2</b>, in this report, and it enhanced the fluorescence intensity. The PPARγ ligand <b>2</b> maintained the rosiglitazone activity. The obtained partial agonist <b>6</b> appeared to act through a novel mechanism. The fluorescence intensity of <b>2</b> and <b>6</b> increased by binding to the ligand binding domain (LBD) of PPARγ and the affinity of reported PPARγ ligands were evaluated using the probe.
ISSN:1661-6596
1422-0067